Our study demonstrated that genetic deletion of P2Y2R confers a significant resistance to HFD-induced obesity by decreasing hepatic steatosis, evidenced by a reduction in hepatic triglycerides and NAFLD activity scores. The gene discussed is P2RY2; the disease is metabolic dysfunction-associated steatotic liver disease.